Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
about
Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brainAssessing the percent of necrosis after neoadjuvant chemotherapy with 24hr infusional cisplatin/3 days Doxorubicin intermittent with Ifosfamide-Doxorubicin for osteosarcoma.Osteosarcoma Overview.Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective studyFertility following treatment of high-grade malignant bone and soft tissue tumors in young adults.Improvement in High-Grade Osteosarcoma Survival: Results from 202 Patients Treated at a Single Institution in TaiwanTrps1 is associated with the multidrug resistance of osteosarcoma by regulating MDR1 gene expression.Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials.Treatment of osteosarcoma around the knee in skeletally immature patients.Solitary breast cancer metastasis to pelvic bone treated with a unique method of surgery combined with local doxorubicin administration.Knee reconstruction with endoprosthesis after extra-articular and intra-articular resection of osteosarcoma.Trial Watch: Chemotherapy with immunogenic cell death inducers.Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway.Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan
P2860
Q27331875-951E5FEB-0AB9-4761-A6C2-4D7B967B84ADQ33413207-67C059BD-588A-4A13-A0F6-8A1F0B7C8708Q33725511-5926FE71-13B9-44CE-B47D-0DE7583CB76FQ33758207-8E55A062-01C8-4939-BB2C-F2F99D583FFEQ35179978-40DF89F7-0CC2-4DB9-97D8-F67852FEA5DEQ36822586-8CF52098-8CB2-42C6-AB82-F95666DEFD16Q39027625-6B4BDC11-A837-4783-B089-6A5DD9312214Q41002762-B9F5CF48-AEF6-4491-861E-92495EA37EDFQ43588156-34391705-3A5E-4AB9-98D8-46CC4F71B7B4Q43654763-D0EED910-63BA-4517-A64B-BE5651046CE5Q47118141-A3FCB488-7E05-4280-93F6-300EC2754F15Q49195700-99C58D3C-61E6-43D9-BA0E-1CAD40011C70Q53493398-7D62422E-04BE-41B3-A06C-12E6F606EB62Q55260834-ABDB2ED8-CFD0-4C6D-9558-414C2F914577Q55332538-DB46D033-0E10-472B-8C91-812D108E35CCQ58766971-2F8FB43C-CA95-4442-89B6-9DA558365192
P2860
Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Neoadjuvant and adjuvant chemo ...... es: a phase II trial in Japan.
@en
Neoadjuvant and adjuvant chemo ...... es: a phase II trial in Japan.
@nl
type
label
Neoadjuvant and adjuvant chemo ...... es: a phase II trial in Japan.
@en
Neoadjuvant and adjuvant chemo ...... es: a phase II trial in Japan.
@nl
prefLabel
Neoadjuvant and adjuvant chemo ...... es: a phase II trial in Japan.
@en
Neoadjuvant and adjuvant chemo ...... es: a phase II trial in Japan.
@nl
P2093
P2860
P1476
Neoadjuvant and adjuvant chemo ...... es: a phase II trial in Japan.
@en
P2093
Akihiko Matsumine
Akira Myoui
Hideki Yoshikawa
Hirofumi Nakanishi
Ikuo Kudawara
Makoto Ieguchi
Nobuhito Araki
Nobuyuki Hashimoto
Norifumi Naka
Shigeki Mori
P2860
P356
10.1179/1973947812Y.0000000055
P577
2013-02-01T00:00:00Z